Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing: A Cluster Randomized Clinical Trial

IMPORTANCE: Colony-stimulating factors are prescribed to patients undergoing chemotherapy to reduce the risk of febrile neutropenia. Research suggests that 55% to 95% of colony-stimulating factor prescribing is inconsistent with national guidelines. OBJECTIVE: To examine whether a guideline-based st...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramsey, Scott D., Bansal, Aasthaa, Sullivan, Sean D., Lyman, Gary H., Barlow, William E., Arnold, Kathryn B., Watabayashi, Kate, Bell-Brown, Ari, Kreizenbeck, Karma, Le-Lindqwister, Nguyet A., Dul, Carrie L., Brown-Glaberman, Ursa A., Behrens, Robert J., Vogel, Victor, Alluri, Nitya, Hershman, Dawn L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593234/
https://www.ncbi.nlm.nih.gov/pubmed/36279134
http://dx.doi.org/10.1001/jamanetworkopen.2022.38191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593234/
https://www.ncbi.nlm.nih.gov/pubmed/36279134
http://dx.doi.org/10.1001/jamanetworkopen.2022.38191

Ejemplares similares